𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results in Fifty Cases of Advanced Squamous Cell Carcinoma of the Head and Neck Treated by Intravenous Chemotherapy

✍ Scribed by Priestman, T J

Book ID
109833237
Publisher
Nature Publishing Group
Year
1973
Tongue
English
Weight
735 KB
Volume
27
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy for advanced sq
Combination chemotherapy for advanced squamous cell carcinoma of the head and neck
✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman πŸ“‚ Article πŸ“… 1981 πŸ› Wiley (John Wiley & Sons) βš– 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), Β± high dose methotrexate (MTX). Thirty‐th

Adjuvant chemotherapy for advanced head
Adjuvant chemotherapy for advanced head and neck squamous carcinoma
✍ Final report of the head; neck contracts program πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 1016 KB

To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta

Preoperative sequential chemotherapy in
Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck
✍ Sandrine Faivre; Adina Marti; Olivier Rixe; FranΓ§ois Janot; Morbize Julieron; Mi πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 2 views

## Abstract ## Background. Induction chemotherapy may contribute to decreased local and distant recurrences in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) resectable for cure. ## Methods. Patients with previously untreated locally advanced stage III–IV (N0